OPHTHALMIC FORMULATIONS

The present invention is directed to ophthalmic formulations comprising trehalose, mannitol and a cellulose ether and their use in the treatment of corneal epithelial defects.

Saved in:
Bibliographic Details
Main Authors DRAGANI, Maria Concetta, GENTILE, Marco Maria, MANTELLI, Flavio
Format Patent
LanguageEnglish
French
German
Published 02.06.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to ophthalmic formulations comprising trehalose, mannitol and a cellulose ether and their use in the treatment of corneal epithelial defects.
Bibliography:Application Number: EP20200209808